Extended normobaric hyperoxia therapy yields greater neuroprotection for focal transient ischemia-reperfusion in rats

BACKGROUND: Normobaric hyperoxia (NBO) therapy is neuroprotective in acute ischemic stroke. However, how long the NBO should last to obtain optimal outcome is still unclear. Reports show that ischemic penumbra blood supply may remain compromised for a long period after ischemia-reperfusion, which wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zhongrui, Pan, Rong, Liu, Wenlan, Liu, Ke Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149308/
https://www.ncbi.nlm.nih.gov/pubmed/25177481
http://dx.doi.org/10.1186/2045-9912-4-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149308/
https://www.ncbi.nlm.nih.gov/pubmed/25177481
http://dx.doi.org/10.1186/2045-9912-4-14

Ejemplares similares